# PharmaCyte Biotech, Inc.: Form SCHEDULE 13D/A, filed Nov 18, 2025

- Company: [PharmaCyte Biotech, Inc.](/companies/pmcb.md) (CIK 1157075)
- Form: SCHEDULE 13D/A
- Filed: 2025-11-18
- Accepted by EDGAR: Nov 18, 2025, 21:29 ET
- Period: not reported
- Accession: 0001683168-25-008515
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1157075/000168316825008515/xslSCHEDULE_13D_X01/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1157075/000168316825008515/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1157075/000168316825008515/xslSCHEDULE_13D_X01/primary_doc.xml

Filed Nov 18, 2025.
Source: SEC EDGAR, the filing index for accession 0001683168-25-008515. Last ingested by Listed: Oct 24, 2026, 15:05 ET. No prices; not investment advice.